Cargando…
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
SIMPLE SUMMARY: Prostate cancer is the most frequent cancer type and one of the leading causes of death in men globally. Multiple biomarkers analyzed in urine have been proposed for detecting prostate cancer, in an effort to reduce unnecessary and invasive biopsies. Nevertheless, these biomarkers ar...
Autores principales: | Frantzi, Maria, Culig, Zoran, Heidegger, Isabel, Mokou, Marika, Latosinska, Agnieszka, Roesch, Marie C., Merseburger, Axel S., Makridakis, Manousos, Vlahou, Antonia, Blanca-Pedregosa, Ana, Carrasco-Valiente, Julia, Mischak, Harald, Gomez-Gomez, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954607/ https://www.ncbi.nlm.nih.gov/pubmed/36831508 http://dx.doi.org/10.3390/cancers15041166 |
Ejemplares similares
-
CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2019) -
Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2022) -
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention
por: Latosinska, Agnieszka, et al.
Publicado: (2017) -
Integrative analysis of extracellular and intracellular bladder cancer cell line proteome with transcriptome: improving coverage and validity of –omics findings
por: Latosinska, Agnieszka, et al.
Publicado: (2016) -
Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation
por: Latosinska, Agnieszka, et al.
Publicado: (2020)